E Haoran

机构：Suzhou Municipal Hospital

发表论文 18 篇 · 总被引 252 次 · h-index 9

代表论文

• The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study (2022 · Cancer Immunology Immunotherapy · 被引 61)
• Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer (2022 · Lung Cancer · 被引 39)
• Utility of 18F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer (2023 · Lung Cancer · 被引 26)
• A modified T categorization for part-solid lesions in Chinese patients with clinical stage I Non–small cell lung cancer (2020 · Lung Cancer · 被引 24)
• Clinical utility of [18F]FDG PET/CT in the assessment of mediastinal lymph node disease after neoadjuvant chemoimmunotherapy for non-small cell lung cancer (2023 · European Radiology · 被引 13)
• The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy (2023 · Therapeutic Advances in Medical Oncology · 被引 12)